Bài đăng

Hiển thị các bài đăng có nhãn 2022 at 10:46AM

Vietnamese Economy Records Positive Indexes This Year: Russian Expert

Hình ảnh
. Rating agencies and the World Bank also forecast Vietnam’s growth at 6.5-7% this year and coming years. Photo: Business Forum According to Russia’s Sputnik radio, Mazyrin described GDP growth as the most outstanding success of Vietnam. Rating agencies and the World Bank also forecast Vietnam’s growth at 6.5-7% this year and coming years. In his view, 4-5% growth is also a great success of Vietnam as many countries posted negative growth amid Covid-19. Given that industrial production growth stood at roughly 9% in 11 months of this year, he said industry remains a major industry of the Vietnamese economy and Vietnam has made progress in its goal of becoming a manufacturing workshop of the world. During the period, foreign direct investment in Vietnam reached $25 billion, lower than 5% recorded in the same period last year. However, he still believed that the figure is high. He noted that capital absorption rate in Vietnam improved markedly, which rose by 15% to some $...

Hong Kong Baptist University develops new aptamer drug for bone anabolic therapies

Hình ảnh
HONG KONG SAR – Media OutReach – 19 December 2022 – A research team led by Hong Kong Baptist University (HKBU) has identified a molecular target for bone anabolic therapies using a selected aptamer that serves as an inhibitor of sclerostin, a protein that prevents bone growth. The discovery offers hope for the development of an effective next-generation treatment for osteoporosis and osteogenesis imperfecta that is free of cardiovascular risk compared to the marketed antibody drug. (From left) Dr Yu Yuanyuan, Professor Lyu Aiping, Professor Zhang Ge, and Dr Wang Luyao, Post-Doctoral Research Fellow of the Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases at HKBU, develop the new aptamer drug for osteoporosis and osteogenesis imperfecta. The research findings have been published in the international academic journals Nature Communications and Theranostics . The New drug is at the pre-clinical trial development stage, and the research team pla...